The AbsorbaSeal Vascular Closure Device Trial
Prospective, Multi-center, Non-Randomized Controlled Trial of Vascular Closure Using the AbsorbaSeal 6 French Vascular Closure Device
Sponsor: CyndRx, LLC
Terminated
Insufficient closure
Other Peripheral Arterial Disease trials with similar outcome
Listed as NCT03730571, this NA trial focuses on Peripheral Arterial Disease and remains terminated or withdrawn. Sponsored by CyndRx, LLC, it has been updated 7 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Oct 2021 — Jul 2024 [monthly]
Terminated NA
-
Feb 2021 — Oct 2021 [monthly]
Terminated NA
Status: Unknown Status → Terminated
-
Jan 2021 — Feb 2021 [monthly]
Unknown Status NA
▶ Show 2 earlier versions
-
Oct 2020 — Jan 2021 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Dec 2018 — Oct 2020 [monthly]
Recruiting NA
First recorded
Aug 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- CyndRx, LLC
- ID3 Medical
For direct contact, visit the study record on ClinicalTrials.gov .